Teladoc Health (TDOC) Enterprise Value (2013 - 2026)

Teladoc Health has disclosed Enterprise Value across 14 years of filings, most recently posting -$750.7 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$750.7 million, up 37.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$750.7 million (up 37.09% YoY), and the FY2025 annual result was -$781.1 million, up 39.84% from the prior year.
• Enterprise Value came in at -$750.7 million for Q1 2026 at Teladoc Health, up from -$781.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$679.6 million in Q2 2025 to a low of -$1.3 billion in Q4 2024.
• The 5-year median for Enterprise Value is -$918.2 million (2022), against an average of -$969.1 million.
• Across the five-year window, Enterprise Value fell 23.56% in 2024 and jumped 41.61% in 2025, its largest moves.
• Teladoc Health's Enterprise Value stood at -$918.2 million in 2022, then slipped by 22.38% to -$1.1 billion in 2023, then retreated by 15.54% to -$1.3 billion in 2024, then surged by 39.84% to -$781.1 million in 2025, then increased by 3.89% to -$750.7 million in 2026.
• The last three Enterprise Value figures came in at -$750.7 million (Q1 2026), -$781.1 million (Q4 2025), and -$726.2 million (Q3 2025), per Business Quant data.